QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.127415v1 323/3/838    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knoll, A. T. Articles by Carlezon, W. A. Search for Related Content PubMed PubMed Citation Articles by Knoll, A. T. Articles by Carlezon, W. A., Jr.

NEUROPHARMACOLOGY

Anxiolytic-Like Effects of -Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats

Behavioral Genetics Laboratory, Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts (A.T.K., E.G.M., W.A.C.); and Research Triangle Institute, Organic and Medicinal Chemistry, Research Triangle Park, North Carolina (J.B.T., F.I.C.)

Endogenous opioid systems regulate neurobiological responses to threatening stimuli. Stimulation of -opioid receptors (KORs) produces analgesia but induces prodepressive-like effects in a variety of animal models. In contrast, KOR antagonists have antidepressant-like effects. KORs and their endogenous ligand dynorphin are expressed throughout brain areas involved in fear and anxiety, including the extended amygdala. Here, we examined whether KOR antagonists would affect unlearned fear (anxiety) in the elevated plus maze (EPM) and open field (OF) paradigms and learned fear in the fear-potentiated startle (FPS) paradigm. These studies were designed to accommodate the slow onset (24 h) and extended time course (>3 weeks) of the prototypical KOR antagonists nor-binaltorphimine hydrochloride (norBNI) and JDTic [(3R)-7-hydroxy-N-[(1S)-1-[[(3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinoline-carboxamide hydrochloride]. Rats received an i.p. injection of norBNI (3.0–30 mg/kg) or JDTic (1.0–10 mg/kg) 48 h before EPM testing. One day later, they were tested in the OF, and 5 and 7 days later, they were trained and tested in the FPS paradigm. Both KOR antagonists dose-dependently increased open arm exploration in the EPM without affecting OF behavior. They also decreased conditioned fear in the FPS paradigm. The anxiolytic-like effects of KOR antagonists were qualitatively similar to those of the benzodiazepine chlordiazepoxide in the EPM. The selective serotonin reuptake inhibitor fluoxetine had no effect in the EPM and anxiogenic-like effects in the OF. Our results indicate that KOR antagonists produce a unique combination of antidepressant- and anxiolytic-like effects and suggest that this class of drugs may be particularly effective for the treatment of comorbid depressive and anxiety disorders.

Address correspondence to: Dr. William A. Carlezon Jr., Department of Psychiatry, McLean Hospital, MRC 217, 115 Mill Street, Belmont, MA 02478. E-mail: bcarlezon{at}mclean.harvard.edu

This article has been cited by other articles:

				R. Maiya, Y. Zhou, E. H. Norris, M. J. Kreek, and S. Strickland Tissue plasminogen activator modulates the cellular and behavioral response to cocaine PNAS, February 10, 2009; 106(6): 1983 - 1988. [Abstract] [Full Text] [PDF]

				Y. Chen, C. Chen, E. Kotsikorou, D. L. Lynch, P. H. Reggio, and L.-Y. Liu-Chen GEC1-{kappa} Opioid Receptor Binding Involves Hydrophobic Interactions: GEC1 HAS CHAPERONE-LIKE EFFECT J. Biol. Chem., January 16, 2009; 284(3): 1673 - 1685. [Abstract] [Full Text] [PDF]